COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,889 Articles (22,568 medRxiv, 8,321 bioRxiv)

Most recent first Previous |  Page 672: Articles 6711-6720  | Next

Landscape of infection enhancing antibodies in COVID-19 and healthy donors
Ismanto, H. S., Xu, Z., Saputri, D. S., Wilamowski, J., Li, S., Nugraha, D. K., Horiguchi, Y., Okada, M., Arase, H., Standley, D. M.
10.1101/2022.07.09.499414 — Posted: 2022-07-11
Evolution of SARS-CoV-2 during the first year of the COVID-19 pandemic in Northwestern Argentina
Zambrana Montano, R., Culasso, A., Fernandez, F., Marquez, N., Debat, H., Salmeron, M., Zamora, A. M., Ruiz de Huidobro, G., Costas, D., Alabarse, G., Charre, M., Fridman, A., Mamani, C., Vaca, F., Maza Diaz, C., Raskovsky, V., Lavaque, E., Lesser, V., Cajal, P., Aguero, F., Calvente, C., Torres, C., Viegas, M.
10.1101/2022.07.08.499374 — Posted: 2022-07-11
The impact of COVID-19 on prescribing of pancreatic enzyme replacement therapy for people with unresectable pancreatic cancer in England. A cohort study using OpenSafely-TPP
Lemanska, A., Andrews, C. D., Fisher, L., Butler-Cole, B., Mehrkar, A., Roberts, K. J., Goldacre, B., Walker, A. J., MacKenna, B.
10.1101/2022.07.08.22277317 — Posted: 2022-07-10
Modeling infections and deaths averted due to COVID-19 vaccination strategies in Ghana
Ofori, S. K., Schwind, J. S., Sullivan, K. L., Chowell, G., Cowling, B. J., Fung, I. C.-H.
10.1101/2022.07.09.22277458 — Posted: 2022-07-10
Examining the Impact of Increasing Vaccine Coverage and Nonpharmaceutical Interventions against Coronavirus Disease 2019 In Ghana using Mathematical Modeling
Ofori, S. K., Schwind, J. S., Sullivan, K. L., Chowell, G., Cowling, B. J., Fung, I. C.-H.
10.1101/2022.07.09.22277456 — Posted: 2022-07-10
Human Epidemiology and RespOnse to SARS-CoV-2 (HEROS): Objectives, Design and Enrollment Results of a 12-City Remote Observational Surveillance Study of Households with Children using Direct-to-Participant Methods
Fulkerson, P., Lussier, S., Bendixsen, C., Castina, S., Gebretsadik, T., Marlin, J., Russell, P., Seibold, M., Everman, J., Moore, C., Snyder, B., Thompson, K., Tregoning, G., Wellford, S., Arbes, S., Bacharier, L., Calatroni, A., Camrgo, C., Dupont, W., Furuta, G., Gruchalla, R., Gupta, R., Hershey, G. K., Jackson, D. J., Johnson, C. C., Kattan, M., Liu, A. H., Murrison, L., O'Connor, G. T., Phipatanakul, W., Rivera-Spoljaric, K., Rothenberg, M. E., Seroogy, C., Teach, S., Zoratti, E., Togias, A., Hartert, T.
10.1101/2022.07.09.22277457 — Posted: 2022-07-10
Covid-19 vaccination and menstrual cycle length in the Apple Women's Health Study
Gibson, E. A., Li, H., Fruh, V., Gabra, M. P., Asokan, G., Jukic, A. M. Z., Baird, D. D., Curry, C. L., Fischer-Colbrie, T., Onnela, J.-P., Williams, M. A., Hauser, R., Coull, B. A., Mahalingaiah, S.
10.1101/2022.07.07.22277371 — Posted: 2022-07-10
Altered affinity to ACE2 and reduced Fc functional antibodies to SARS-CoV-2 RBD variants
Haycroft, E. R., Davis, S. K., Ramanathan, P., Lopez, E., Purcell, R. A., Tan, L. L., Pymm, P., Wines, B. D., Hogarth, P. M., Wheatley, A. K., Juno, J. A., Redmond, S., Gheradin, N. A., Godfrey, D., Tham, W.-H., John Selva, K., Kent, S., Chung, A. W.
10.1101/2022.07.07.22277364 — Posted: 2022-07-10
Class switch towards non-inflammatory IgG isotypes after repeated SARS-CoV-2 mRNA vaccination
Irrgang, P., Gerling, J., Kocher, K., Lapuente, D., Steininger, P., Wytopil, M., Schäfer, S., Habenicht, K., Zhong, J., Ssebyatika, G., Krey, T., Falcone, V., Schülein, C., Peter, A. S., Nganou-Makamdop, K., Hengel, H., Held, J., Bogdan, C., Überla, K., Schober, K., Winkler, T. H., Tenbusch, M.
10.1101/2022.07.05.22277189 — Posted: 2022-07-10
Modeling the impact of the Omicron infection wave in Germany
Maier, B. F., Burdinski, A., Wiedermann, M., Rose, A. H., an der Heiden, M., Wichmann, O., Harder, T., Schlosser, F., Brockmann, D.
10.1101/2022.07.07.22277391 — Posted: 2022-07-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).